Coverage dated September 28, 2026 to September 29, 2026

Researchers slow neurodegeneration in mice by barring T cells from the brain

Headline from STAT

A new study in mice led by Washington University in St. Louis researchers suggests that stopping certain immune cells from entering the brain could limit neurodegeneration.

STAT's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

3 articles, oldest first.

MedicalXpress
Blocking immune cells' path into the brain limits neurodegeneration (opens MedicalXpress)
Published Sep 28, 2026
MedicalXpress's feed description
There is no treatment available today to stop the death of brain cells in neurodegenerative diseases known as tauopathies, including Alzheimer's disease, in which twisted clumps of a protein called tau accumulate in the brain.
Geneng News
Antibody Blocks T Cell Infiltration and Limits Neurodegeneration in Alzheimer’s Mice (opens Geneng News)
Published Sep 28, 2026
Geneng News's feed description
Researchers developed a potential antibody-based approach to reducing neurodegeneration in tauopathies, with studies showing that in a mouse Alzheimer’s model anti-CXCR3-treated animals retained more brain tissue and had better memory, even though tau levels stayed the same.
STAT
Researchers slow neurodegeneration in mice by barring T cells from the brain (opens STAT)
Published Sep 29, 2026
STAT's feed description
A new study in mice led by Washington University in St. Louis researchers suggests that stopping certain immune cells from entering the brain could limit neurodegeneration.